The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The High-Fidelity Long-Read Sequencing Market Progress Between 2026 And 2030?
The market size for high-fidelity long-read sequencing has experienced substantial growth in recent years. It is anticipated to increase from $1.53 billion in 2025 to $1.88 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 22.2%. The historical growth in this sector is attributable to advancements in sequencing chemistry accuracy, early adoption in genomics research institutions, expansion of large-scale genome projects, increasing demand for structural variant analysis, and improvements in sequencing hardware performance.
The high-fidelity long-read sequencing market is anticipated to experience substantial growth in the coming years. It is projected to reach $4.22 billion by 2030, growing at a compound annual growth rate (CAGR) of 22.5%. This expansion during the forecast period is fueled by factors such as the expanding application of precision medicine approaches, increasing investments in genomics-based drug discovery, the broadening scope of rare disease research, greater clinical adoption of long-read sequencing, and improvements in sequencing cost efficiency. Key trends for this period include the rising incorporation of long-read sequencing in clinical diagnostics, a heightened demand for high-accuracy variant detection, the increasing use of de novo genome assembly techniques, an expansion in epigenetic and transcriptomic analysis applications, and enhanced integration of advanced bioinformatics tools.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=33166&type=smp
Which Important Drivers Are Guiding The High-Fidelity Long-Read Sequencing Market Growth?
The growing incidence of rare diseases is projected to stimulate the HiFi long-read sequencing market’s expansion moving forward. These conditions are characterized by impacting a small segment of the population, often presenting intricate symptoms and limited therapeutic options. The increase in rare diseases is attributed to advancements in genetic sequencing and diagnostic technologies, which facilitate earlier and more precise identification of previously unrecognized or misdiagnosed conditions. HiFi long-read sequencing offers a solution for rare diseases by enabling highly accurate and comprehensive detection of complex genetic variations frequently overlooked by short-read sequencing, thereby leading to quicker and more accurate diagnoses. For instance, in July 2023, the Department of Health & Social Care, a UK-based government body, estimated that there are over 7,000 rare diseases, with new ones continuously being identified as research advances. Approximately 80% of these rare diseases are known to have a genetic foundation. Consequently, the increasing prevalence of rare diseases is a key factor propelling the growth of the HiFi long-read sequencing market.
How Is Segmentation Applied In The High-Fidelity Long-Read Sequencing Market Segment Analysis?
The high-fidelity long-read sequencing market covered in this report is segmented –
1) By Product Type: Instruments; Consumables; Software
2) By Sequencing Technology: Single-Molecule Real-Time Sequencing; Nanopore Sequencing; Other Sequencing Technologies
3) By Application: Clinical Diagnostics; Genomics Research; Oncology; Rare Disease Detection; Agriculture And Animal Research; Other Applications
4) By End-User: Academic And Research Institutes; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End-Users
Subsegments:
1) By Instruments: Sequencers; Library Preparation Systems; Sample Preparation Instruments; Data Collection Devices; Quality Control Instruments
2) By Consumables: Sequencing Kits; Flow Cells; Reagents; Pipette Tips; Sample Tubes
3) By Software: Data Analysis Software; Visualization Software; Sequence Alignment Software; Genome Assembly Software; Quality Assessment Software
What Trends Are Influencing The Evolution Of The High-Fidelity Long-Read Sequencing Market?
Leading companies in the HiFi long-read sequencing market are concentrating on developing innovative solutions, such as hybrid-capture target enrichment, to enhance sequencing accuracy, increase coverage of complex genomic regions, and accelerate the detection of structural variants for advanced research and clinical applications. Hybrid-capture target enrichment refers to a genomic sequencing technique that selectively isolates specific regions of DNA or RNA from a sample using complementary probes, allowing for focused, high-accuracy sequencing of target regions while reducing sequencing of non-relevant areas. For instance, in July 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq xHYB Long Read Panels to expand its next-generation sequencing (NGS) offerings. These panels utilize hybrid-capture enrichment to enable precise long-read sequencing of complex genomic regions like repeats and structural variants, overcoming short-read limitations. They provide superior uniformity, specificity, and complete coverage for applications in cancer profiling, HLA typing, and haplotype phasing, with flexible fixed or custom formats and integrated workflows from DNA prep to bioinformatics analysis. Benefits include streamlined efficiency and deeper insights for precision medicine.
Who Are The Companies Participating In The High-Fidelity Long-Read Sequencing Market Environment?
Major companies operating in the high-fidelity long-read sequencing market are Azenta Inc., BGI Genomics Co. Ltd., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Pacific Biosciences of California Inc., Macrogen Inc., MedGenome Inc., MGI Tech Co. Ltd., Discovery Life Sciences Inc., Eurofins Genomics LLC, CD Genomics, BaseClear B.V., Psomagen Inc., Health in Code S.L., Creative Biogene Inc., Nucleome Informatics Private Limited, Genevia Technologies Oy, JS Link Co. Ltd., SeqCenter LLC, Theragen Bio Co. Ltd.
Get The Full High-Fidelity Long-Read Sequencing Market Report:
https://www.thebusinessresearchcompany.com/report/high-fidelity-long-read-sequencing-market-report
Where Is The High-Fidelity Long-Read Sequencing Market Primarily Concentrated By Region?
North America was the largest region in the HiFi long-read sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the high-fidelity long-read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized High-Fidelity Long-Read Sequencing Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=33166&type=smp
Browse Through More Reports Similar to the Global High-Fidelity Long-Read Sequencing Market 2026, By The Business Research Company
Next Generation Sequencing Market 2026
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Short Read Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report
Clinical Oncology Next Generation Sequencing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model